Send me a link:

*Text messaging rates may apply.

 Dow Down 0.28% Nasdaq Down 0.17%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
3.45 0.05(1.47%) Jul 21, 4:02PM EDT
Prev Close:3.40
Open:3.35
Bid:3.39 x 4000
Ask:3.43 x 300
1y Target Est:5.95
Beta:1.28
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:3.30 - 3.50
52wk Range:3.16 - 5.64
Volume:1,373,060
Avg Vol (3m):228,252
Market Cap:319.77M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PLX

Comparison

Symbol% ChgMkt Cap
PLXUp 1.47%319.77M
SHPG49.41B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-0.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback